Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.
Leveraging Development Strengths Drives Therapies to Market
NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.
Single-Use Continuous Chromatography Overcoming Limitations of Traditional Protein Purification
Continuous countercurrent tangential chromatography (CCTC) is a column-free process that provides a scalable, disposable, and cost-saving alternative to column chromatography.
EMD Millipore, PharmaCell Collaborate on Large-Scale Bioreactor Production of Stem Cells
EMD Millipore and PharmaCell have entered into a collaboration to develop optimized large-scale expansion and harvest of HepaRG cells using bioreactor technology.
Growth of Bio-Process Systems Alliance Reflects Rising Interest in Single-Use Technologies
Kevin Ott, executive director of the Bio-Process Systems Alliance, discusses the latest trends and issues surrounding single-use technologies and the role of his association.